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doi:10.1016/j.jfma.2010.10.002Background/Purpose: Umbilical cord blood is rich in primitive natural killer (NK) cells, which
are activated by interleukin (IL)-12. It was previously reported that a novel IL-12 family cyto-
kine, IL-27 comprised of EBI3 and p28, was elevated in maternal serum during normal preg-
nancy. Thus, we compared the immune regulatory functions of IL-27 and IL-12 on
mononuclear cells derived from cord blood and adult peripheral blood.
Methods: After stimulation with IL-27, IL-12, and IL-27 combined with IL-12, the cytotoxicity
against BJAB lymphoma cells by blood mononuclear cells was performed. Then immunofluores-
cence staining, reverse transcriptase-polymerase chain reaction and Western blotting were
used to detect the effects of IL-27 and IL-12 in isolated NK cells.
Results: IL-27, IL-12, and IL-27 combined with IL-12 enhanced the cytotoxicity of adult periph-
eral blood cells and cord blood cells, but the proliferation of distinct subpopulations of cells
was not evident. Similar results were also obtained with purified cord blood NK cells. Interest-
ingly, distinct from IL-12, IL-27 could induce aggregation and morphological changes of umbil-
ical cord blood cells. Finally, IL-27 combined with IL-12 could stimulate increased IL-27
receptor (gp130 and WSX-1) transcripts in purified cord blood NK cells. However, the activation
of signal transducer and activator of transcription 3 (STAT3) in NK cells was only detected in
the presence of IL-27, but not IL-12 alone.edicine, Fu Jen Catholic University, 510 Chung-Cheng Road, New Taipei City 24205, Taiwan.
.edu.tw (Y.-T. Huang).
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276 J.-C. Chen et al.Conclusion: From previous results, we summarize our current understanding of the augmenta-
tion of distinct regulation of NK cells by IL-27 and IL-12.
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Numerous tumor cells or microbe-infected cells can escape
the cytotoxicity of CD8þ T-cells by downregulating major
histocompatability complex (MHC) class I complex and
accessory molecules. However, these deficient cells may be
eliminated as the targets of natural killer (NK) cells. NK
cells are one of the cellular mediators of innate immune
responses that do not require adaptive immunization.
During developmental progression, NK cells express various
cell surface molecules and cytokine receptors, which are
markers that can be used to identify the stages of NK cell
development.1 In addition, upon cytokine stimulation and
transcription factor activation, NK cells can progress to
mature stages, at which time they can produce interferon-
gamma and enhance cytotoxicity via the production of
perforins and granzymes. The cytotoxic capability of NK
cells is regulated by the balance of signals mediated by
inhibitory and activating receptors of NK cells.2,3 On the
surfaces of target cells, self-MHC class I molecule expres-
sion is a crucial signal for inhibition, whereas ligands for
the very large ITAM-bearing or DAP10-associated trans-
ducing receptors are involved with activation.4 In addition,
the signals arising from cytokine receptors, when inte-
grated with paracrine interleukin (IL)-12, IL-15, tumor
necrosis factor-alpha, and interferons, are also involved in
the maturation and activation of NK cells.5
IL-12 enhances the responses of T-helper type 1 (Th1)
cells and reactivation of memory CD4þ T-cells.6e8 Addi-
tional evidence supports its critical roles for priming the
cytotoxicity of CD8þ T-cells and NK cells by promoting the
expression of cytolytic factors, such as perforin and gran-
zymes.9,10 IL-27, a novel member of the IL-12 family, is
composed of the EpsteineBarr viral-induced gene 3 (EBI3)
and p28. EBI3 is an IL-12 p40-related protein, and p28 is
a newly discovered IL-12 p35-related protein.11 In recent
studies, IL-27 also had the ability to enhance the trend
toward Th1 immune responses by inducing the Th1-specific
transcription factor T-bet.12 In addition, IL-27 was shown to
have potent antitumor activity as it acted directly on CD8þ
T-cells and enhanced granzyme B expression.13
The biological functions of IL-12 are dependent on the
IL-12 receptor subunits b1 and b2 expressed on CD4þ
T-cells, CD8þ T-cells, and NK cells.14,15 Recently, receptors
for IL-27 were defined. These included a homolog of the
IL-12 receptor b2 subunit, WSX-1 (T-cell cytokine receptor),
and a functional signal transducing receptor, gp130.11,16
Compared with IL-12 receptors, the presence of WSX-1/
gp130 receptors indicates that IL-27 has other biological
functions distinguishable from those of IL-12. WSX-1 can be
constitutively expressed by a range of lymphoid cells,
including NK, NKT, CD4þ T, and CD8þ T-cells.17
gp130 is widely expressed in various organs. It is
a common signal transducer of the IL-6 family, including
IL-6, leukemia inhibitory factor, IL-11, ciliary neurotrophicfactor, oncostatin M, cardiotropin-1, and stimulating
neurotrophin-1/B-cell stimulating factor-3.18 Activation of
gp130 can promote cell proliferation and survival, leading
to the inhibition of an apoptotic signaling pathway.19,20
gp130, as an initial cell signal transducer, leads to activa-
tion of the Janus kinase/signal transducer and activator of
transcription (JAK/STAT) pathways in naive CD4þ T-cells
and enhances their proliferation.21,22 Recently, studies
have indicated that IL-27 enhances lymphocyte differenti-
ation via two distinct independent pathways: p38 MAPK/
T-bet and ICAM-1/LFA-1/ERK1/2.23,24
Although the functions of IL-27 in the development and
activation of human T-cells have been reasonably well
defined, information regarding the signals from IL-27 to
regulate human NK cell cytotoxicity is very limited.
Therefore, additional definitions of the functions of IL-27 in
NK cells would be valuable for understanding its mecha-
nisms related to innate immunity. In this study, expression
systems for IL-27 and IL-12 were established in vitro. We
demonstrate that IL-27 and IL-12 augment the activation of
distinct cytotoxicity responses of BMCs from adult periph-
eral blood and cord blood. In addition, enhanced cytotoxic
activity was confirmed using isolated cord blood NK cells.
Further, activation of several transduction mediators,
including the IL-27 receptor (gp130 and WSX-1) and STAT3,
were defined in the IL-27- and IL-12-responsive cells.Materials and methods
Expressions of IL-27, IL-12, and EBI3
Expression plasmids for IL-27 (EBI3-FLAG/pRK5F and p28-
FLAG/pRK5F) and IL-12 (p40-FLAG/pRK5F and p35-FLAG/
pRK5F) were generated based on a pRK5F vector that con-
tained a CMV promoter/enhancer and FLAG terminus. The
gene for EBI3 was amplified from a human placenta
complementary DNA (cDNA) library. The p28 gene was
derived from an embryonic stem cell clone. The genes for
the two subunits of IL-12, p40 and p35, were derived from
phytohemagglutinin-stimulated human peripheral BMCs.
The open reading frames of EBI3, p28, p40, and p35 were
amplified using polymerase chain reaction (PCR) technology
and then inserted into pRK5F vectors. The expression
plasmids for IL-27, IL-12, IL-27þIL-12, and EBI3 were
transfected into 293 T cells using the method of CaCl2
transfection.
The supernatants derived from transient 293 T trans-
fectants were analyzed by Western blotting using anti-FLAG
M2 monoclonal antibodies, and then expressions of the
IL-27 (EBI3 and p28) and IL-12 (p40 and p35) heterodimers
were detected. In addition, when IL-27- and IL-12-specific
enzyme-linked immunosorbent assay (ELISA; eBioscience,
California, CA, USA) was used, the IL-27 and IL-12 proteins
expressed in all 293 T transfectants were found to be
Table 1 Nucleotide sequences of primers for the reverse
transcription polymerase chain reaction.
Target genes
(size of products)
Nucleotide sequence
gp130 (168 bp)
Forward primer 50-ATACCTTAAACAAGCTCCACCTTC-30
Reverse primer 50-AGTTTCATTTCCAATGATGGTTCT-30
WSX-1 (183 bp)
Forward primer 50-GAAACCCAAATGAAGCCAAA-30
Reverse primer 50-GCCTCCTGACATCTTCGGTA-30
GAPDH (108 bp)
Forward primer 50-TTGGTATCGTGGAAGGACTC-30
Reverse primer 50-CAGTAGAGGCAGGGATGAT-30
GAPDH Z glyceraldehyde 3-phosphate dehydrogenase.
Effect of IL-27 on cord blood natural killer cells 277appreciable and identical. Finally, similar concentrations of
IL-27 (150 ng/mL), IL-12 (150 ng/mL), and IL-27þIL-12
(containing 150 ng/mL IL-27 and approximately 150 ng/mL
IL-12) were used for stimulating BMCs and NK cells.
Isolation of BMCs from cord blood and adult
peripheral blood
All human blood samples, either adult peripheral blood or
cord blood, were obtained with the approval of the Insti-
tutional Review Board of Fu Jen Catholic University (IRB No.
C9717). Blood was centrifuged at 250 g for 20 minutes at
room temperature to separate the cells from the plasma.
The plasma was removed, blood cells were mixed with
an equal volume of RPMI 1640 medium containing 10%
fetal bovine serum (FBS), and these were then layered
onto Ficoll-Hypaque (Pharmacia, Uppsala, Sweden). After
centrifuging at 250 g for 30 minutes, the buffy coat at the
interphase was collected. The isolated BMCs were resus-
pended in RPMI 1640 medium supplemented with 10% FBS,
2 mM glutamine, 50 U/mL penicillin, and 50 mg/mL strep-
tomycin, and were used for cytotoxicity assays.
Isolation of NK cells
Blood cells were incubated with CD56e and CD16e selection
paramagnetic beads and then layered onto Ficoll-Hypaque.
NK cells were negatively selected from cells using markers
for CD3, CD4, CD19, CD36, and CD66b from a Human NK
Cell Enrichment Cocktail (Rosette Sep. StemCell Technol-
ogies, Inc., Vancouver, BC, Canada). After centrifuging at
1000 g for 30 minutes, the buffy coat at the interphase was
collected and the cells were washed once with RPMI 1640
medium. The washed isolated NK cells were resuspended
in medium supplemented with 10% FBS and were used
for cytotoxicity assays. Isolated NK cells were confirmed
by immunoflow cytometry, with a purity of up to 86%.
These isolated NK cells were used for cytotoxicity assays,
and their total protein was extracted and prepared for
immunoblotting.
Cell culture
NK cells, BMCs, and BJAB lymphoma cells were cultured in
RPMI 1640 medium containing 10% FBS, 2 mM glutamine, 50
units/mL penicillin, and 50 mg/mL streptomycin. 293 T cells
were incubated in Dulbecco’s Modified Eagle Medium-based
medium with 10% FBS, 2 mM glutamine, 50 U/mL penicillin,
and 50 mg/mL streptomycin.
Cytotoxicity assay
According to the manufacturer’s instructions, the standard
assays of LIVE/DEAD Cell-Mediated Cytotoxicity (Molecular
Probes, Inc, Eugene, OR, USA) were modified to measure NK
cell-mediated cytotoxicity by fluorescence flow cytometry
assays. The target BJAB cells were labeled with green
fluorescent DiOC18 (FL1), and then combined in various
proportions with effector cells. After cellecell contact for 4
hours at 37C, the nucleic acid from all the cells was
counterstained with propidium iodide (PI). Dead targetcells with green fluorescence membrane (FL1) and red
fluorescence nuclei (FL3) staining were analyzed by flow
cytometry. BJAB target cells killed by NK cells were then
identified by double-fluorescent staining (a double positive
region of FL1 and FL3). The proportion of killed cells was
determined by comparison with total target cell numbers.
Flow cytometry
Cell suspensions obtained from peripheral BMCs, cord blood
BMCs, or purified NK cells were pelleted and resuspended
in staining medium (RPMI 1640 containing 1% FBS and
0.1% sodium azide). Various fluorescein isothiocyanate- or
phycoerythrin-conjugated monoclonal antibodies, directed
against CD4, CD8, CD16, and CD56 (all from BioLegend, San
Diego, California, USA), were added to the staining
medium. After 1 hour’s incubation at 4 C, unbound
monoclonal antibody was removed by washing the cells
with washing medium (phosphate-buffered saline plus 1%
FBS and 0.1% sodium azide). Cell pellets were resuspended
in staining buffer and analyzed by immunoflow cytometry
on a FACScan (Becton Dickinson Biosciences, San Jose, CA,
USA) using BD CellQuest software.
Reverse transcription PCR
Total RNA was extracted from cells using REzol C&T reagent
(Protech Technology Co, Taipei, Taiwan) according to the
manufacturer’s instructions. Single-stranded cDNA was
then generated in a 20 mL reverse transcription (RT) reac-
tion volume containing 1 mg RNA as template, random
primers, and SuperScript II RNase He reverse transcriptase
(Promega Co, Madison WI, USA). RT products (1 mL) were
used for PCR amplification in a 50 mL reaction volume
containing sense and antisense primers for gp130 and WSX-1
(400 nM), dATP, dGTP, dTTP, and dCTP mixture (each 200
mM), 1  PCR reaction buffer, and DNA polymerase (Pro-
tech Technology Co). PCR products were electrophoresed
on 1.6% agarose gels and visualized with ethidium bromide
staining under ultraviolet light. Simultaneously, transcripts
encoding glyceraldehyde 3-phosphate dehydrogenase were
monitored in all samples and served as an internal control.
The primers used are shown in Table 1.
Figure 1 Stimulation effects of IL-27 and IL-12 on cytotoxic
activity of BMCs derived from adults or cord blood. (A) BMCs
collected from cord blood were stimulated with IL-27 (150 ng/
mL), IL-12 (150 ng/mL), or IL-27þIL-12 (containing 150 ng/mL
IL-27 and approximate 150 ng/mL IL-12) for 24 hrs, and then
278 J.-C. Chen et al.Western blot assays
Culture supernatants (10 mL) collected from 293 T cell
transfectants were incubated with lysis buffer [0.6% NP-40,
154 mM NaCl, 10 mM Tris-HCl (pH7.4), 1 mM EDTA, and 0.1%
sodium dodecyl sulfate (SDS)] for 5 minutes, and then the
expressions of IL-27 and IL-12 were examined. To detect
STAT3 and phospho-STAT3, IL-27- or IL-12-stimulated BMCs or
purified NK cells were washed with phosphate-buffered
saline, and then incubated with lysis buffer for 5 minutes.
Cells were sonicated on ice for 2 minutes, and cell lysates
were cleared by centrifugation at 14,000 g for 10 minutes.
Culture supernatants or cell lysates were resolved by 10%
SDS-polyacrylamide gel electrophoresis (Bionovas Biotech-
nologyCo., Toronto, ON, Canada). The isolatedproteinswere
transferred to a nitrocellulose membrane. The membrane
was reacted with primary monoclonal antibodies recognizing
FLAG peptide (M2 monoclonal antibodies; Sigma, Inc, Saint
Louis, MO, USA), STAT3 (Cell Signaling Technology, Inc,
Danvers, MA, USA), or phospho-STAT3 (Cell Signaling Tech-
nology, Inc), followed by horseradish peroxidase-conjugated
secondary antibody (Millipore, Inc, Billerica, MA, USA). The
blot was developed using enhanced chemiluminescence.
Statistical analysis
Results are given as means  standard errors of the mean.
Statistical comparisons between two groups used the
Student t test. Analysis of variance followed by Scheffe’s
test was used for multiple group comparisons. A p value of
<0.05 was considered to be statistically significant.
Results
IL-27 and IL-12 enhance the cytotoxic activities of
BMCs derived from adult peripheral blood and cord
blood
It is well known that IL-12 enhances the cytotoxicity of NK
cells.25 In addition, the two subunits of the IL-27 hetero-
dimer are similar to those of IL-12. In an attempt to define
functional characteristics of IL-27 and IL-12, the cytotoxic
activity of NK cells was employed based on assay systems
of cell-mediated cytotoxicity (Fig. 1). As described above,used as effector cells. DiOC18-labeled BJAB lymphoma cells
were as the target cells. Activated BMCs were co-cultured with
target cells at an effector cell to target cell ratio of 50:1 for 4
hrs, and then total cells were stained with PI. Inset shows flow
cytometric profiles of an aliquot of the target cells stained with
DiOC18 (FL1) and PI (FL3). The percentages of dead target cells
were determined by double-positive fluorescence cells/total
FL1 positive cells in the cytotoxic activity assays. BMCs
collected from (B) cord blood or (C) adult peripheral blood
were stimulated with IL-27, IL-12, IL-27þIL-12, or EBI3 for 24
hrs, and the cytotoxic activity assays were performed. Results
(mean  SEM) are representative of five independent experi-
ments. (*p < 0.05 vs. vector control at an effector cell to
target cell ratio of 25:1, #p < 0.05 vs. vector control at an
effector cell to target cell ratio of 50:1).
Effect of IL-27 on cord blood natural killer cells 279isolated cord blood BMC effector cells were co-cultured
with DiOC18-labeled BJAB lymphoma target cells in
different proportions (BMC to BJAB cell ratios of 50:1). After
cellecell contact for 4 hours, nucleic acid was counter-
stained with PI. It should be noted that, distinct from
antigen-specific cytotoxic T-cells, NK cells only require short
periods of antigen stimulation and kill target cells within
several hours. The dead BJAB target cells had concomitant
staining with DiOC18 in the cell membrane and PI staining
of the nuclei; these were analyzed by flow cytometry.
Thus, target cells killed by NK cells had double fluorescent
labels (a double positive region of FL1 and FL3). The
proportion of cells killed due to cytotoxicity was determined
by the percentage of double-positive cells with reference
to the total number of DiOC18-labeled target cells.
The BMCs from adult peripheral blood and cord blood
were analyzed. After stimulation with IL-27 (150 ng/mL),
IL-12 (150 ng/mL), IL-27þIL-12 (containing 150 ng/mL IL-27
and approximately 150 ng/mL IL-12), and EBI3 (150 ng/mL)
for 24 hours, the percentages of lysed BJAB target cells
were determined. These results showed that IL-27 and IL-12
could enhance the cytotoxic activities of BMCs derived from
cord blood (Fig. 1) and adult peripheral blood (Fig. 1). In
addition, IL-27 combined with IL-12 significantly promoted
this killing activity. Interestingly, the cytotoxic activity of
BMCs derived from cord blood was higher than that of BMCs
derived from adult peripheral blood. IL-27þIL-12 signifi-
cantly stimulated cord blood BMCs at an effector to target
cell ratio of 1:50. However, EBI3 alone, one subunit ofFigure 2 Observation of aggregated cord blood cells after stim
were isolated and cultured in medium containing interleukin (IL)-2
150 ng/mL IL-27 and approximately 150 ng/mL IL-12). After 48 hou
morphologies of cord BMCs were observed on the culture dish usinIL-27, did not induce cytotoxicity of BMCs derived from
either peripheral blood or cord blood.
IL-27 stimulates aggregation of BMCs
In order to examine the activation characteristics of IL-27
compared with those of IL-12 on BMCs, we observed that
the morphologies of cord blood BMCs changed when they
were cultured in medium containing IL-27 (150 ng/mL),
IL-12 (150 ng/mL), and IL-27þIL-12 (containing 150 ng/mL
IL-27 and approximately 150 ng/mL IL-12) for 48 hours.
After removing the culture supernatants and suspended
cells, a considerable number of BMCs were found to be
adherent to the culture dishes when stimulated with IL-27
and IL-27þIL-12 (Fig. 2). In addition, IL-27 and IL-27þIL-12
stimulated BMCs to form aggregates. These aggregated
BMCs were shown to contain 41% CD4þ, 22% CD8þ, and 10%
NK cells using specific antibodies against cell surface
markers and immunofluorescence staining (data not
shown). These results indicated that Th cells, cytotoxic T
(Tc) cells, and NK cells were stimulated in the presence of
IL-27 and IL-27þIL-12.
Activation of cytotoxicity does not result from
proliferating BMC subpopulations
In order to exclude cell proliferation from IL-27-enhanced
stimulation, we determined the numbers and percentagesulation with cytokines. Cord blood mononuclear cells (BMCs)
7 (150 ng/mL), IL-12 (150 ng/mL), and IL-27þIL-12 (containing
rs, cells in suspension were removed and the distributions and
g a light microscope.
280 J.-C. Chen et al.of cell subpopulations among BMCs stimulated with cyto-
kines. After stimulation with IL-27, IL-12, and IL-27þIL-12
for 48 hours, cell subpopulations of BMCs derived from
adult peripheral blood cord blood were determined as
described above. As shown in Fig. 3, among adult peripheral
and cord blood BMCs, Th cells (CD4þ), Tc cells (CD8þ), and
NK cells (CD16þCD56e and CD16þCD56þ) were significantly
detected. As shown in Fig. 3, there was no change in the
absolute number of cells after stimulation with IL-27, IL-12,
and IL-27þIL-12 for 2 days. This indicated that IL-27 or IL-12
would not induce cellular proliferation during a short period
of time. However, compared with the vector control, the
percentages of Th, Tc, and NK cells were similar after
stimulation with either IL-27 or IL-12. Therefore, theA
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Figure 3 Percentages of cell subpopulations of blood
mononuclear cells (BMCs) derived from adult peripheral blood
or cord blood after stimulation with interleukin (IL)-27/IL-12.
Cells in suspension for BMCs from adult peripheral blood (A) or
cord blood (B) were stimulated with IL-27 (150 ng/mL), IL-12
(150 ng/mL), and IL-27þIL-12 (containing 150 ng/mL IL-27
and approximately 150 ng/mL IL-12) for 2 days. Stimulated
BMCs were stained with fluorescent-labeled monoclonal anti-
bodies against CD3 and CD4 [markers of T helper lymphocytes
(Th cells)], CD3 and CD8 [markers of cytotoxic T lymphocytes
(Tc cells)] or CD56 and CD16 (markers of NK cells). The
phenotypes of the cells in the stimulated BMCs were analyzed
using an immunoflow cytometric assay.absolute numbers of Th, Tc, and NK cells in cord blood were
consistent and identical after treatment with cytokines.
IL-27 stimulates the cytotoxic activity of purified
NK cells derived from cord blood
Cord blood BMCs were stimulated with IL-27 (150 ng/mL),
IL-12 (150 ng/mL), and IL-27þIL-12 (containing 150 ng/mL
IL-27 and approximately 150 ng/mL IL-12) for 18 hours.
NK cells were then purified by negative selection methods.
The isolated NK cells were confirmed by immunoflow
cytometry, with a purity of up to 86%. These purified NK
cells were subsequently co-cultured with BJAB target cells
for 4 hours. The cytotoxic capability of these purified NK
cells was determined as described above. As shown in
Fig. 4, compared with a vector control, cell-mediated-
cytotoxicity was enhanced after stimulation with IL-27,
IL-12, or IL-27þIL-12.
IL-27 induces the expression of IL-27 receptors and
the phosphorylation of STAT3 in cord blood NK cells
It has been shown that IL-27 activates T-cells via IL-27
receptors (gp130 and WSX-1). Therefore, we sought to
confirm whether IL-27 activation of NK cells could also
occur through similar pathways. NK cells purified from cord
blood BMCs were stimulated with IL-27 for 36 hours, and
then IL-27 receptor transcripts (gp130 and WSX-1) were
detected by RT-PCR. Fig. 5A shows that WSX-1 was consti-
tutively expressed by NK cells. Interestingly, IL-27þIL-12
(containing 150 ng/mL IL-27 and approximately 150 ng/mL
IL-12) was able to induce the expression of gp130. This
indicated that IL-27 receptors could be detected in the NK
cells of cord blood, especially in the presence of IL-12þ
IL-27. In addition, activation signaling was confirmed inFigure 4 Cytotoxic activity of interleukin (IL)-27/IL-12-
stimulated purified natural killer (NK) cells from cord blood.
Fresh paramagnetic bead-selected NK cells were isolated from
cord blood and then stimulated with vector control, IL-27, IL-
12, IL-27 þ IL-12, or EBI3 for 24 hours. The percentages of BJAB
cells killed by cytokine-pretreated NK cells were determined
for an NK cell to target cell ratio of 2:1. The results (mean 
standard errors of the mean) were representative of three
independent experiments. *p < 0.05 versus vector control.
Figure 5 Regulation of interleukin (IL)-27/IL-12 in freshly
isolated cord blood cells. (A) Expression of gp130 in isolated
cord blood natural killer (NK) cells. After stimulation with or
without IL-27þIL-12 (containing 150 ng/mL IL-27 and approxi-
mately 150 ng/mL IL-12) for 24 hours, purified NK cells were
collected. Cord blood NK cells were then isolated using
microbeads, and the transcripts for IL-27 receptors (gp130
and WSX-1) were detected by the reverse transcription poly-
merase chain reaction. The transcripts of phytohemagglutinin-
stimulated adult peripheral blood mononuclear cells (PBMCs)
were used as a positive control. (B) IL-27 and IL-12 signaling in
isolated cord blood NK cells. NK cells from cord blood were
stimulated with IL-27 (150 ng/mL), IL-12 (150 ng/mL), IL-
27þIL-12 (containing 150 ng/mL IL-27 and approximately
150 ng/mL IL-12), or EBI3 (150 ng/mL). After 4 hours, total
protein was isolated from stimulated NK cells, and STAT3
activation signals were detected by phospho-STAT3 (p-STAT3)
and STAT3 immunoblotting. Phosphorylated STAT3 levels
were normalized to total protein levels, and were presented as
band densities. The results (mean  standard error of the
mean) were representative of at least three independent
experiments. *p < 0.05 versus vector control. GAPDH Z
glyceraldehyde 3-phosphate dehydrogenase.
Effect of IL-27 on cord blood natural killer cells 281stimulated NK cells. After adding IL-27 (150 ng/mL), IL-12
(150 ng/mL), or IL-27þIL-12 (containing 150 ng/mL IL-27
and approximately 150 ng/mL IL-12) to purified cord
blood NK cells for 4 hours, total cellular protein was iso-
lated. It is known that gp130 can induce the activation of
STATs; therefore, STAT3 and phospho-STAT3 expression by
NK cells was analyzed by Western blotting. The results,
shown in Fig. 5B, indicate that IL-27, as well as IL-27þIL-12,
enhanced the expression of phospho-STAT3 in cord blood
NK cells. However, IL-12 had no effects on stimulating
STAT3. These results indicated that IL-27 activated cord
blood NK cells via gp130 and STAT3 pathways.Discussion
In this study, we have defined immunomodulatory activities
of IL-27 and IL-12 when acting on cord blood cells and
adult peripheral BMCs. We first constructed plasmids con-
taining genes for EBI3, p28, p40, and p35, and established
expression systems for IL-27 and IL-12 in transfectants.
Cytotoxicity assays for NK cells were also established
in vitro. Our results showed that IL-27, IL-12, and IL-27þ
IL-12 could enhance the cytotoxicity capability of adult
peripheral BMCs (Fig. 1). Moreover, as shown in Fig. 1,
IL-27, IL-12, and IL-27þIL-12 significantly augmented the
cytotoxicity and activity of umbilical cord blood cells. This
revealed that umbilical cord blood cells were more sensi-
tive to stimulation by IL-27/IL-12. However, these results
do not rule out the possibility that other subpopulations of
umbilical cord blood cells contribute to cellular cytolysis.
Therefore, we isolated cord blood NK cells and deter-
mined the killing capability of these cells in the presence
of IL-27 and IL-12. Interestingly, IL-27/IL-12 did indeed
enhance the activities of cord blood NK cells (Fig. 4). It is
known that IL-27 is elevated in the placenta and maternal
serum during normal pregnancy.26,27 We also investigated
whether IL-27 receptors (gp130 and WSX-1) were detect-
able in umbilical cord blood NK cells, especially after
stimulation with IL-27 and IL-12. Our results indicated that
gp130 protein may be inducible, and that IL-27 takes
a period of time (24e48 hours) for induction of its activa-
tion (Fig. 5A). In addition, experiments to define the signals
underlying the immune enhancement effects of IL-27 were
carried out, as shown in Fig. 5B.
IL-12 family members include IL-27, IL-23, and IL-35,
based on their subunit combinations and receptor struc-
tures. It has previously been shown that each IL-12 family
member contributes to the differentiation of Th cells with
different roles. After stimulation with 150 ng/mL of IL-27 or
IL-12, IL-27 showed an ability to stimulate BMC clumping,
compared with IL-12. This indicated that IL-27 might induce
more adhesion molecules, such as ICAM-1/LFA-1, or
CCR5dan interesting topic for further studies.
IL-12 receptors b1 and b2 triggered the activation of
JAK-STAT signaling pathways during Th1 differentiation,
and STAT1 and STAT4 were the predominant mediators. In
addition, IL-23 triggered the development of memory Th1
cells and the differentiation of Th17 cells via the activation
of STAT3 and STAT4.14 IL-27 is a key cytokine to drive Th0
cells to become Th1 cells during the initiation of Th1 cell
differentiation via STAT1 and STAT3. However, during IL-27
282 J.-C. Chen et al.stimulation, phosphorylation of STAT3 was detected in the
isolated cord blood NK cells. This result has also been
observed with murine DX-5þ NK cells.24 By comparison with
IL-27, stimulation with IL-12 did not enhance the activation
of STAT3 in cord blood NK cells. In conjunction with our
results, this indicates that IL-27 and IL-12 affect the
cytotoxicity of NK cells through different receptor/signal
pathways.
Recently, cytokine inhibitory proteins, suppressors of
cytokine signaling (SOCS), were discovered, and their
functions associated with the IL-12/IL-6 family were
defined.28,29 IL-12-induced activation of T-cell proliferation
and NK cell cytotoxicity were enhanced in SOCS-deficient
cells. Further, in the absence of SOCS expression, IL-27
was able to enhance the proliferation of murine T-cells. In
our study, cord blood BMCs showed greater activation than
adult peripheral BMCs in response to IL-27. Therefore, after
stimulation with IL-27, the expressions and contributions of
SOCS proteins in cord blood BMCs warrant investigation.
NK cells are derived from adult human hematopoietic
stem cells in the bone marrow. During developmental
progression, NK cells can express a variety of cell surface
molecules and cytokine receptors, markers that can be
used to identify the stages of NK cell development.30e34 In
addition, using cytokine stimulation and transcription
factor activation, NK cells progress to mature stages, at
which time they can become cytotoxic and produce
interferon-gamma. Studies of mice or humans with gene
deficiencies for cytokine receptors or nuclear factors have
shown that the microenvironment could affect the devel-
opment and differentiation of NK cells.
It has been shown that umbilical cord blood is a possible
alternative source for allogeneic stem cell transplantation.35
However, umbilical cord blood is rich in primitive NK cells,
which are expanded by host cytokines and posses cytotoxic
capacities. This could give rise to substantial graft reactions
when used for treating leukemia.36,37 Therefore, based on
our results, we would anticipate that the application of
IL-27, with characteristics of cytotoxicity regulation, could
improve the side effects associated with allogeneic stem
cell transplant therapy. The enhanced responses of cord
blood NK cells to IL-27 may also contribute to neonatal
immune defense and antitumor effects during cord blood
stem cell transplantation.38,39
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